Exciting conversations are happening around the future of pharmaceutical manufacturing, and our latest podcast interview with Andy Lundin (Senior Editor at Pharma Manufacturing) brings this to life.
In this episode, our Strategic Director and Founder, Dr. Dirk Kirschneck, and Dr. Christoph Brücher of VP Global Business Transformation & Licensing of Hovione discuss how flow chemistry, process intensification, and modular automation are reshaping the path from development to commercial manufacturing.
🔹 Why Flow?
Flow chemistry provides consistent, high-performance conditions and unlocks process flexibility — the “high-performance vehicle” compared to traditional batch approaches.
🔹 Why Modular?
Think LEGO-like plant design: standardized, prequalified modules that can be combined, scaled, and reconfigured quickly to meet process needs.
🔹 Why Now?
The pharmaceutical industry is moving toward accelerated development timelines, digital twins, and advanced PAT tools. Modular continuous systems are a natural fit.
From seamless scale-up across platforms like FlowKiloLab® and FlowTonPlant, to the use of MTP protocols enabling plug-and-play automation, Dirk and Christoph share how this partnership pushes the boundaries of speed, quality, and digitalization.
A big thank you to Andy for hosting a forward-looking discussion, and to everyone helping shape the next chapter in pharma manufacturing innovation.